Showing results (591-600 of 833) with videos related to

Sort By:
Pageof 84
Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
The Journal of Infectious Diseases|November 6, 2004
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study groupA Mocroft, B Ledergerber, J P Viard, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
Clinical and Experimental Immunology|November 25, 2000
Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternallyC Ostergaard, R V Yieng-Kow, C G Larsen, et al.
International Journal of Epidemiology|April 1, 1997
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study GroupA J Mocroft, J D Lundgren, A d'Armino Monforte, et al.
The Journal of Infectious Diseases|January 25, 2002
A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA studyJens D Lundgren, Amanda Mocroft, Jose M Gatell, et al.
Annals of Internal Medicine|September 4, 2008
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial, W M El-Sadr, B Grund, et al.
The Journal of Infectious Diseases|June 15, 2004
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA studyUlrik Bak Dragsted, Amanda Mocroft, Stefano Vella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2008
Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) studyEllen Tedaldi, Lars Peters, Jacquie Neuhaus, et al.
Pageof 84